3
Announcements
Trials
Browse
Landscape
Phase
Phase 3
2
Status
Recruiting
1
Active not recruiting
1
Sponsor Class
OTHER
2
Study Type
Interventional
2
Sponsor
Cancer Type
Breast
1
Conditions
Breast Neoplasms
157
Carcinoma, Intraductal, Noninfiltrating
16
Breast Carcinoma In Situ
12
Neoplasm Metastasis
9
Ovarian Neoplasms
7
Breast Neoplasms, Male
7
Neoplasms
4
Prostatic Neoplasms
3
Inflammatory Breast Neoplasms
3
Glioblastoma
3
Breast Cancer Female
3
Urinary Bladder Neoplasms
2
Recurrence
2
Pancreatic Neoplasms
2
Obesity
2
Infertility
2
Hot Flashes
2
Fibroadenoma
2
Fallopian Tube Neoplasms
2
Endometrial Neoplasms
2
ER+ Breast Cancer
2
Brain Neoplasms
2
Uterine Cervical Neoplasms
1
Triple Negative Breast Neoplasms
1
Sleep Wake Disorders
1
Sexuality
1
Risk Reduction Behavior
1
Rhabdoid Tumor
1
Pyloric Stenosis, Hypertrophic
1
Primary Breast Cancer
1
Interventions
Clomiphene
18
Metformin
12
Letrozole
11
Triptorelin Pamoate
7
cetrorelix
5
Menotropins
5
Chorionic Gonadotropin
4
Surveys and Questionnaires
3
Sperm Injections, Intracytoplasmic
3
Medroxyprogesterone Acetate
3
Inositol
3
Gonadotropins
3
Folic Acid
3
Uterine Myomectomy
2
Tamoxifen
2
Sugars
2
Progestins
2
Liraglutide
2
High-Energy Shock Waves
2
Flutamide
2
ulipristal acetate
1
testosterone undecanoate
1
methyl N-acetylsibirosaminide
1
hMG-IBSA
1
follitropin alfa
1
drospirenone and ethinyl estradiol combination
1
drospirenone
1
Thyrotropin
1
Thioctic Acid
1
Therapeutics
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
2 trials
Recent
Start date
Enrollment
OTHER
×
Infertility
×
Tamoxifen
×
Clear all
NCT03011684
2026-06-04
TALES
University of California, San Francisco
Phase 3
Recruiting
309 enrolled
NCT07616973
2026-06-01
LET-CC-TAM
Sana'a University
Phase 3
Active not recruiting
240 enrolled